Clinical Trials Directory

Trials / Conditions / Stage IIIC Rectal Cancer

Stage IIIC Rectal Cancer

24 registered clinical trials studyying Stage IIIC Rectal Cancer.

StatusTrialSponsorPhase
TerminatedEncorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Can
NCT04044430
University of California, San FranciscoPhase 1
CompletedHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
NCT03154190
Stanford UniversityN/A
CompletedCPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surg
NCT02232152
Wake Forest University Health SciencesPhase 1
CompletedPhase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer
NCT02270606
Virginia Commonwealth UniversityPhase 1
CompletedPrograms to Support You During Chemotherapy (Pro-You)
NCT02148406
Vanderbilt-Ingram Cancer CenterN/A
CompletedGenetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Adv
NCT02132858
Fox Chase Cancer Center—
TerminatedTelomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemot
NCT01934179
Fox Chase Cancer Center—
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
UnknownBevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage
NCT01871571
University of Southern CaliforniaPhase 2
CompletedPET-MRI in Diagnosing Patients With Colon or Rectal Cancer
NCT01807117
Case Comprehensive Cancer CenterN/A
CompletedAkt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or
NCT01802320
National Cancer Institute (NCI)Phase 2
CompletedAdherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorect
NCT01726296
Fox Chase Cancer CenterN/A
CompletedSurvivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer
NCT01741636
City of Hope Medical CenterN/A
CompletedTrametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal C
NCT01740648
Ohio State University Comprehensive Cancer CenterPhase 1
CompletedGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest
NCT01643499
University of ChicagoPhase 1
TerminatedParicalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed
NCT01197664
Wake Forest University Health SciencesPhase 1
CompletedGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
NCT01131234
National Cancer Institute (NCI)Phase 1
CompletedErlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
NCT00754494
National Cancer Institute (NCI)Phase 2
CompletedSB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT00103311
National Cancer Institute (NCI)Phase 2
CompletedGTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Ca
NCT00084643
National Cancer Institute (NCI)Phase 1
CompletedA Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, an
NCT00060411
National Cancer Institute (NCI)Phase 1
CompletedIrinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00005036
National Cancer Institute (NCI)Phase 3
CompletedChemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer
NCT00003799
National Cancer Institute (NCI)Phase 1
WithdrawnPan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic P
NCT02575508
Roswell Park Cancer InstitutePhase 1 / Phase 2